YS Biopharma Co., Ltd. (YS)

NASDAQ: YS · IEX Real-Time Price · USD
+0.01 (0.67%)
May 31, 2023, 3:59 PM EDT - Market closed

Total Valuation

YS has a market cap or net worth of $140.52 million. The enterprise value is $173.50 million.

Market Cap 140.52M
Enterprise Value 173.50M

Important Dates

The last earnings date was Friday, May 12, 2023.

Earnings Date May 12, 2023
Ex-Dividend Date n/a

Share Statistics

YS has 93.06 million shares outstanding. The number of shares has decreased by -0.07% in one year.

Shares Outstanding 93.06M
Shares Change (YoY) -0.07%
Shares Change (QoQ) +859.77%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.11
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.37
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.52

Current Ratio 1.52
Quick Ratio 1.22
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -37.30%
Return on Capital (ROIC) -14.30%
Revenue Per Employee $146,705
Profits Per Employee -$51,405
Employee Count 865
Asset Turnover 1.06
Inventory Turnover n/a


In the past 12 months, YS has paid $773,749 in taxes.

Income Tax 773,749
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.96
200-Day Moving Average NaN
Average Volume (30 Days) 812,061

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, YS had revenue of $126.90 million and -$44.47 million in losses. Loss per share was -$0.01.

Revenue 126.90M
Gross Profit 97.26M
Operating Income -19.20M
Pretax Income -15.18M
Net Income -44.47M
EBIT -12.70M
Loss Per Share -$0.01
Full Income Statement

Balance Sheet

The company has $31.92 million in cash and $64.90 million in debt, giving a net cash position of -$32.98 million or -$0.35 per share.

Cash & Cash Equivalents 31.92M
Total Debt 64.90M
Net Cash -32.98M
Net Cash Per Share -$0.35
Equity / Book Value -133.68M
Book Value Per Share -1.44
Working Capital 41.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -39.44M
Capital Expenditures n/a
Free Cash Flow -39.44M
FCF Per Share -$0.16
Full Cash Flow Statement


Gross margin is 76.65%, with operating and profit margins of -15.13% and -35.04%.

Gross Margin 76.65%
Operating Margin -15.13%
Pretax Margin -11.96%
Profit Margin -35.04%
EBITDA Margin -3.96%
EBIT Margin -10.01%
FCF Margin -31.08%

Dividends & Yields

YS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -31.64%
FCF Yield -28.07%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield 0.07%
Shareholder Yield 0.07%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a